Targeting multiple oncogenic pathways for the treatment of hepatocellular carcinoma.
about
Selective targeted delivery of doxorubicin via conjugating to anti-CD24 antibody results in enhanced antitumor potency for hepatocellular carcinoma both in vitro and in vivo.A qRT-PCR and Gene Functional Enrichment Study Focused on Downregulation of miR-141-3p in Hepatocellular Carcinoma and Its Clinicopathological Significance.Sorafenib: A Review in Hepatocellular Carcinoma.Engineering a high-affinity humanized anti-CD24 antibody to target hepatocellular carcinoma by a novel CDR grafting design.Micelle-enhanced direct spectrofluorimetric method for the determination of linifanib: Application to stability studies.N-Substituted Pyrido-1,4-Oxazin-3-Ones Induce Apoptosis of Hepatocellular Carcinoma Cells by Targeting NF-κB Signaling Pathway
P2860
Targeting multiple oncogenic pathways for the treatment of hepatocellular carcinoma.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Targeting multiple oncogenic pathways for the treatment of hepatocellular carcinoma.
@en
type
label
Targeting multiple oncogenic pathways for the treatment of hepatocellular carcinoma.
@en
prefLabel
Targeting multiple oncogenic pathways for the treatment of hepatocellular carcinoma.
@en
P2093
P2860
P1433
P1476
Targeting multiple oncogenic pathways for the treatment of hepatocellular carcinoma.
@en
P2093
Anupam Bishayee
Arunasalam Dharmarajan
Chung Yeng Looi
Frank Arfuso
Muthu K Shanmugam
Nanjunda Swamy Shivananju
Priya B Shubha
Supritha G Swamy
Vivek H Kameshwar
P2860
P2888
P356
10.1007/S11523-016-0452-7
P50
P577
2016-08-11T00:00:00Z
P6179
1045213946